文献速递真实世界研究与卫生经济流行病学与生物统计

全膝关节置换实践的影响:基于骨关节炎倡议数据的成本效果分析

Impact of total knee replacement practice: cost effectiveness analysis of data from the Osteoarthritis Initiative.
PubMed 文献 · BMJ · 2017-03-28

基于美国骨关节炎倡议(OAI)4498例膝骨关节炎患者9年随访数据,采用边际结构模型评估全膝关节置换对生活质量的影响并估算终身成本与质量调整生命年(QALY)。在当前实践下,全膝关节置换在组水平对生活质量和QALY影响甚微;若将手术限制于症状更严重的患者(SF-12 PCS<35),在20万美元/QALY的成本效果阈值下为最优场景,可节省成本并仅损失极少量QALY。

要点

  • 当前全膝关节置换实践在组水平对生活质量和QALY影响甚微。
  • 将手术限制于SF-12 PCS<35的患者,在20万美元/QALY阈值下为最优场景。
  • 该场景较当前实践节省6974美元成本,仅损失0.008个QALY。

核心结论

  • 当前美国膝骨关节炎队列中实施的全膝关节置换实践在组水平对生活质量和QALY影响甚微。
  • 若将手术限制于症状更严重的患者,其效果将上升,实践较当前使用更具经济吸引力。

研究设计与样本

  • 基于OAI和MOST两项研究的边际结构模型与成本效果分析,进行全膝关节置换和死亡的终身预测。
  • OAI纳入4498例年龄45-79岁、有膝骨关节炎或高风险且既往无膝关节置换(基线影像学确认)的参与者,随访九年。
  • 验证队列为MOST的2907例患者,随访两年。

主要发现

  • 在OAI中,全膝关节置换在混杂变量各水平平均后显示生活质量改善,但绝对变化较小:SF-12躯体成分总结(PCS)为1.70(95%不确定性区间0.26至3.57);WOMAC为-10.69(-13.39至-8.01);KOOS生活质量子量表为9.16(6.35至12.49)。
  • 基线功能状态越差,上述改善越大。
  • 在20万美元/QALY的成本效果阈值下,对SF-12 PCS评分<35的患者提供全膝关节置换为最优场景,较当前实践节省成本6974美元(5789至8269)并仅损失0.008(-0.056至0.043)个QALY。
  • 上述发现在MOST队列的膝骨关节炎患者中得以重现,且对增加全膝关节置换率和死亡率、纳入非医疗成本等多种场景稳健,但对不手术时生活质量恶化加剧敏感。
  • 阈值分析显示,若相关住院费用降至14000美元以下,在20万美元/QALY的成本效果阈值下,全膝关节置换对SF-12 PCS评分≤40的患者将具有成本效果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objectives To evaluate the impact of total knee replacement on quality of life in people with knee osteoarthritis and to estimate associated differences in lifetime costs and quality adjusted life years (QALYs) according to use by level of symptoms.Design Marginal structural modeling and cost effectiveness analysis based on lifetime predictions for total knee replacement and death from population based cohort data.Setting Data from two studies-Osteoarthritis Initiative (OAI) and the Multicenter Osteoarthritis Study (MOST)-within the US health system.Participants 4498 participants with or at high risk for knee osteoarthritis aged 45-79 from the OAI with no previous knee replacement (confirmed by baseline radiography) followed up for nine years. Validation cohort comprised 2907 patients from MOST with two year follow-up.Intervention Scenarios ranging from current practice, defined as total knee replacement practice as performed in the OAI (with procedural rates estimated by a prediction model), to practice limited to patients with severe symptoms to no surgery.Main outcome measures Generic (SF-12) and osteoarthritis specific quality of life measured over 96 months, model based QALYs, costs, and incremental cost effectiveness ratios over a lifetime horizon.Results In the OAI, total knee replacement showed improvements in quality of life with small absolute changes when averaged across levels of confounding variables: 1.70 (95% uncertainty interval 0.26 to 3.57) for SF-12 physical component summary (PCS); -10.69 (-13.39 to -8.01) for Western Ontario and McMaster Universities arthritis index (WOMAC); and 9.16 (6.35 to 12.49) for knee injury and osteoarthritis outcome score (KOOS) quality of life subscale. These improvements became larger with decreasing functional status at baseline. Provision of total knee replacement to patients with SF-12 PCS scores <35 was the optimal scenario given a cost effectiveness threshold of $200 000/QALY, with cost savings of $6974 ($5789 to $8269) and a minimal loss of 0.008 (-0.056 to 0.043) QALYs compared with current practice. These findings were reproduced among patients with knee osteoarthritis from the MOST cohort and were robust against various scenarios including increased rates of total knee replacement and mortality and inclusion of non-healthcare costs but were sensitive to increased deterioration in quality of life without surgery. In a threshold analysis, total knee replacement would become cost effective in patients with SF-12 PCS scores ≤40 if the associated hospital admission costs fell below $14 000 given a cost effectiveness threshold of $200 000/QALY.Conclusion Current practice of total knee replacement as performed in a recent US cohort of patients with knee osteoarthritis had minimal effects on quality of life and QALYs at the group level. If the procedure were restricted to more severely affected patients, its effectiveness would rise, with practice becoming economically more attractive than its current use.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Ferket BS, Feldman Z, Zhou J, et al. Impact of total knee replacement practice: cost effectiveness analysis of data from the Osteoarthritis Initiative. BMJ. 2017. PMID: 28351833. doi:10.1136/bmj.j1131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。